Jan Cerny to Stem Cell Transplantation
This is a "connection" page, showing publications Jan Cerny has written about Stem Cell Transplantation.
Connection Strength
0.885
-
Sahu KK, Mahagaokar K, Patel B, Winokur D, Suzuki S, Daly JS, Ramanathan M, Cerny J. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting. Ann Hematol. 2021 Apr; 100(4):1089-1091.
Score: 0.665
-
Wang X, Vogt B, Shanahan L, Siddiqui AD, Subramonia-Iyer S, Khanani S, Bednarik JL, Mittal K, Ramanathan M, Gerber JM, Cerny J. Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses. Blood Cells Mol Dis. 2020 11; 85:102482.
Score: 0.169
-
Saini NY, Cerny J, Furtado VF, Desmond A, Zhou Z, Raffel G, Puthawala I, Bednarik J, Shanahan L, Miron PM, Woda B, Ramanathan M, Nath R. Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia. Am J Hematol. 2019 02; 94(2):209-215.
Score: 0.038
-
Dooner M, Cerny J, Colvin G, Demers D, Pimentel J, Greer D, Abedi M, McAuliffe C, Quesenberry P. Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):47-51.
Score: 0.013